Low toxicity and favorable overall survival in relapsed/refractory B-ALL following CAR T cells and CD34-selected T-cell depleted allogeneic hematopoietic cell transplant
CAR-T细胞和CD34选择的T细胞清除异基因造血干细胞移植后,复发/难治性B细胞急性淋巴细胞白血病患者的毒性低,总生存期良好。
期刊:Bone Marrow Transplantation
影响因子:5.2
doi:10.1038/s41409-020-0926-1
Fabrizio, Vanessa A; Kernan, Nancy A; Boulad, Farid; Cancio, Maria; Allen, Jennifer; Higman, Meghan; Margossian, Steven P; Mauguen, Audrey; Prockop, Susan; Scaradavou, Andromachi; Shah, Niketa; Spitzer, Barbara; Stieglitz, Elliot; Yeager, Nicholas; O'Reilly, Richard J; Brentjens, Renier J; Jan Boelens, Jaap; Curran, Kevin J
B细胞
发育与干细胞
T细胞
白血病
CD3
CD34
T细胞
干细胞
细胞生物学
毒理研究
免疫/内分泌